Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-10-01 4:00 pm Purchase | 2026-09-24 | 13G | ANDRX GROUP COM ADRX | BCLS Fund III Investments, LP | 6,728,970 6.300% | 6,728,970 (New Position) | Filing History |
| 2026-08-14 07:00 am Sale | 2026-06-30 | 13G | HEARTFLOW INC HTFL | BCLS Fund III Investments, LP | 8,448,158 9.800% | -2,000,000 (-19.14%) | Filing History |
| 2026-05-15 4:30 pm Sale | 2026-03-31 | 13G | HEARTFLOW INC HTFL | BCLS Fund III Investments, LP | 10,448,158 12.180% | -2,000,000 (-16.07%) | Filing History |
| 2026-02-17 4:30 pm Sale | 2025-12-31 | 13G | CIDARA THERAPEUTICS INC NE CDTX | BCLS Fund III Investments, LP | 0 0.000% | -3,020,990 (Position Closed) | Filing History |
| 2025-11-14 4:30 pm Sale | 2025-09-30 | 13G | DIANTHUS THERAPEUTICS INC DNTH | BCLS Fund III Investments, LP | 1,315,892 3.100% | -1,166,358 (-46.99%) | Filing History |
| 2025-11-14 4:30 pm Purchase | 2025-09-30 | 13G | CIDARA THERAPEUTICS INC NE CDTX | BCLS Fund III Investments, LP | 3,020,990 9.990% | 520,310 (+20.81%) | Filing History |
| 2025-11-14 4:30 pm Purchase | 2025-09-30 | 13G | HEARTFLOW INC HTFL | BCLS Fund III Investments, LP | 12,448,158 14.900% | 12,448,158 (New Position) | Filing History |
| 2025-08-14 4:00 pm Sale | 2025-06-30 | 13G | DIANTHUS THERAPEUTICS INC DNTH | BCLS Fund III Investments, LP | 2,482,250 7.500% | -207,457 (-7.71%) | Filing History |
| 2025-08-14 4:00 pm Purchase | 2025-06-30 | 13G | CIDARA THERAPEUTICS INC NE CDTX | BCLS Fund III Investments, LP | 2,500,680 9.990% | 1,797,600 (+255.68%) | Filing History |
| 2025-02-14 07:54 am Sale | 2024-12-31 | 13G | DIANTHUS THERAPEUTICS INC DNTH | BCLS Fund III Investments, LP | 2,689,707 8.800% | -302,321 (-10.10%) | Filing History |
| 2024-10-18 6:10 pm Purchase | 2024-10-15 | 13G | UPSTREAM BIO INC UPB | BCLS Fund III Investments, LP | 2,295,322 4.300% | 2,295,322 (New Position) | Filing History |
| 2024-07-29 4:45 pm Purchase | 2024-07-18 | 13G | CIDARA THERAPEUTICS INC NE CDTX | BCLS Fund III Investments, LP | 703,080 9.990% | 703,080 (New Position) | Filing History |
| 2024-02-02 4:32 pm Purchase | 2024-01-24 | 13G | DIANTHUS THERAPEUTICS INC DNTH | BCLS Fund III Investments, LP | 2,992,028 9.990% | 2,992,028 (New Position) | Filing History |